Literature DB >> 34982878

Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study.

Hudin N Jackson1, Caroline C Hadley1, A Basit Khan1, Ron Gadot1, James C Bayley1, Arya Shetty1, Jacob Mandel2, Ali Jalali1, K Kelly Gallagher1,3, Alex D Sweeney3, Arif O Harmanci4, Akdes S Harmanci1, Tiemo Klisch5,6, Shankar P Gopinath1, Ganesh Rao1, Daniel Yoshor7, Akash J Patel1,3,6.   

Abstract

BACKGROUND: Meningiomas are the most common intracranial neoplasms. Although genomic analysis has helped elucidate differences in survival, there is evidence that racial disparities may influence outcomes. African Americans have a higher incidence of meningiomas and poorer survival outcomes. The etiology of these disparities remains unclear, but may include a combination of pathophysiology and other factors.
OBJECTIVE: To determine factors that contribute to different clinical outcomes in racial populations.
METHODS: We retrospectively reviewed 305 patients who underwent resection for meningiomas at a single tertiary care facility. We used descriptive statistics and univariate, multivariable, and Kaplan-Meier analyses to study clinical, radiographical, and histopathological differences.
RESULTS: Minority patients were more likely to present through the emergency department than an outpatient clinic (P < .0001). They were more likely to present with more advanced clinical symptoms with lower Karnofsky Performance scores, more frequently had peritumoral edema (P = .0031), and experienced longer postoperative stays in the hospital (P = .0053), and African-American patients had higher hospitalization costs (P = .046) and were more likely to be publicly insured. Extent of resection was an independent predictor of recurrence freedom (P = .039). Presentation in clinic setting trended toward an association with recurrence-free survival (P = .055). We observed no significant difference in gross total resection rates, postoperative recurrence, or recurrence-free survival.
CONCLUSION: Minority patients are more likely to present with severe symptoms, require longer perioperative hospitalization, and generate higher hospitalization costs. This may be due to socioeconomic factors that affect access to health care. Targeting barriers to access, especially to subspecialty care, may facilitate more appropriate and timely diagnosis, thereby improving patient care and outcomes.
Copyright © Congress of Neurological Surgeons 2021. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34982878      PMCID: PMC9514723          DOI: 10.1227/NEU.0000000000001751

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   5.315


  29 in total

1.  Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.

Authors:  Nicholas R Rydzewski; Maciej S Lesniak; James P Chandler; John A Kalapurakal; Erqi Pollom; Matthew C Tate; Orin Bloch; Timothy Kruser; Prarthana Dalal; Sean Sachdev
Journal:  Cancer       Date:  2017-11-13       Impact factor: 6.860

2.  Identification of novel fusion transcripts in meningioma.

Authors:  A Basit Khan; Ron Gadot; Arya Shetty; James C Bayley; Caroline C Hadley; Maria F Cardenas; Ali Jalali; Akdes S Harmanci; Arif O Harmanci; David A Wheeler; Tiemo J Klisch; Akash J Patel
Journal:  J Neurooncol       Date:  2020-09-19       Impact factor: 4.130

3.  Disparities in access to neuro-oncologic care in the United States.

Authors:  Debraj Mukherjee; Hasan A Zaidi; Thomas Kosztowski; Kaisorn L Chaichana; Henry Brem; David C Chang; Alfredo Quiñones-Hinojosa
Journal:  Arch Surg       Date:  2010-03

4.  Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.

Authors:  L Palma; P Celli; C Franco; L Cervoni; G Cantore
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

5.  Simulating How Large Policy Proposals Affect the Black-White Wealth Gap.

Authors:  Christian E Weller; Connor Maxwell; Danyelle Solomon
Journal:  J Econ Race Policy       Date:  2021-01-25

6.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  Atypical meningioma: a study of prognostic factors.

Authors:  Ahmed Zaher; Mohamed Abdelbari Mattar; Dalia H Zayed; Rasha A Ellatif; Sylvia A Ashamallah
Journal:  World Neurosurg       Date:  2013-07-16       Impact factor: 2.104

8.  Racial Differences in Disease Presentation and Management of Intracranial Meningioma.

Authors:  C Lane Anzalone; Amy E Glasgow; Jamie J Van Gompel; Matthew L Carlson
Journal:  J Neurol Surg B Skull Base       Date:  2018-12-21

9.  Admissions Is Not Enough: The Racial Achievement Gap in Medical Education.

Authors:  Alana C Jones; Alana C Nichols; Carmel M McNicholas; Fatima C Stanford
Journal:  Acad Med       Date:  2021-02-01       Impact factor: 7.840

10.  Integrated genomic analyses of de novo pathways underlying atypical meningiomas.

Authors:  Akdes Serin Harmancı; Mark W Youngblood; Victoria E Clark; Süleyman Coşkun; Octavian Henegariu; Daniel Duran; E Zeynep Erson-Omay; Leon D Kaulen; Tong Ihn Lee; Brian J Abraham; Matthias Simon; Boris Krischek; Marco Timmer; Roland Goldbrunner; S Bülent Omay; Jacob Baranoski; Burçin Baran; Geneive Carrión-Grant; Hanwen Bai; Ketu Mishra-Gorur; Johannes Schramm; Jennifer Moliterno; Alexander O Vortmeyer; Kaya Bilgüvar; Katsuhito Yasuno; Richard A Young; Murat Günel
Journal:  Nat Commun       Date:  2017-02-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.